| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
| DIABETES & METABOLISM JOURNAL |
| 2022 | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
| JAMA NETWORK OPEN |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2022 | Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People | HYPERTENSION |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2021 | Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
| DIABETES & METABOLISM JOURNAL |
| 2021 | Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
| Endocrinology and Metabolism(대한내분비학회지) |
| 2021 | Association between domain-specific physical activity and diabetes in Korean adults
| SCIENTIFIC REPORTS |
| 2021 | Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study | DIABETES OBESITY & METABOLISM |
| 2021 | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes | DIABETES OBESITY & METABOLISM |
| 2020 | Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2020 | Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
| BIOMEDICINES |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
| 2020 | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
| 2020 | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
| CARDIOVASCULAR DIABETOLOGY |
| 2020 | SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease
| NATURE COMMUNICATIONS |
| 2020 | Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in Vitro and in Vivo
| JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS |
| 2020 | Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes
| SCIENTIFIC REPORTS |
| 2020 | Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2020 | Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Efficacy and Safety of Gemigliptin as Add-On Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (ZEUS II Study) | DIABETES OBESITY & METABOLISM |
| 2020 | Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
| Journal of Lipid and Atherosclerosis |
| 2020 | Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2020 | Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules | DIABETES OBESITY & METABOLISM |
| 2020 | Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Cohort Profile: Firefighter Research on the Enhancement of Safety and Health (FRESH), a Prospective Cohort Study on Korean Firefighters
| YONSEI MEDICAL JOURNAL |
| 2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
| 2019 | The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | 당뇨병 주사제: Glucagon-Like Peptide-1 수용체작용제
| Journal of Korean Diabetes |
| 2019 | Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
| DIABETES THERAPY |
| 2019 | Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
| SCIENTIFIC REPORTS |
| 2019 | Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors | DIABETES CARE |
| 2019 | Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
| Endocrinology and Metabolism (대한내분비학회지) |
| 2019 | Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria | Journal of Diabetes and Its Complications |
| 2019 | Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors | Cancer Chemotherapy and Pharmacology |
| 2019 | Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study | Diabetologia |
| 2019 | Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide | Diabetes & Metabolism |
| 2019 | Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study
| SCIENTIFIC REPORTS |
| 2019 | Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2019 | Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms | SEMINARS IN LIVER DISEASE |
| 2019 | Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
| DIABETES & METABOLISM JOURNAL |
| 2019 | Reduced expression of pyruvate kinase in kidney proximal tubule cells is a potential mechanism of pravastatin altered glucose metabolism
| SCIENTIFIC REPORTS |
| 2019 | Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk | DIABETES OBESITY & METABOLISM |
| 2019 | Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
| SCIENTIFIC REPORTS |
| 2019 | Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial | DIABETES OBESITY & METABOLISM |
http://orcid.org/0000-0002-0364-4675
(7201795697)
